By

fempharmaadmin

December 7, 2023

In a paper, published in Science Translational Medicine, we have showed that JUVIAGEL could be effective against recurrent yeast infections. More in...
Read More

July 17, 2023

Fempharma has been successfully audited for ISO 13485:2016 Manufacturing and Trade of Medical Devices by Tequa-Zert, a TÜV Hessen partner.

June 25th, 2023

We have presented our latest study “A randomized controlled pilot trial to assess the effectiveness of a specially formulated food supplement and...
Read More

June 22, 2023

Our latest study about the efficacy of INCOXIL has been published at the BMC Women’s Health titled “A randomized controlled pilot trial...
Read More

May 21st, 2023

We have presented our latest study “A randomized controlled trial to assess the effectiveness of a specially formulated food supplement and pelvic...
Read More

May 19th, 2023

New clinical trial for Juvia has started. Vaginitis is one of the most common gynecological problems in women. Candida albicans is responsible...
Read More

May 4th, 2023

Fempharma’s proprietary vaginal moisturizer gel JUVIA has gotten into the shelves at Rossmann Hungary.

April 19th, 2023

Fempharma has been successfully audited for ISO 22000:2018 research and development, contract manufacturing of dietary supplements.